Skip to the page

Data / Form D filings / NexPoint Life Sciences III DST

NexPoint Life Sciences III DST: Form D filings

NexPoint Life Sciences III DST, a real estate company in Dallas, TX, filed 17 Form D notices with the SEC between 2024 and 2026. The latest, on August 11, 2026, reports $28 million sold of a $30.7 million offering to 92 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
300 CRESCENT COURT SUITE 700, Dallas, TX, 75201
Phone
(833) 697-6246
Industry
Other Real Estate
Entity type
Other
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c), Investment Company Act section 3(c), section 3(c)(1), 3C.5
SEC identifier (CIK)
2008210

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 11, 2026Amendment$30,661,253$27,965,695$2,695,55892Jan 25, 2024sec.gov
Jan 13, 2026Amendment$30,661,253$25,178,789$5,482,46481Jan 25, 2024sec.gov
Aug 6, 2025Amendment$30,661,253$14,150,789$16,510,46459Jan 25, 2024sec.gov
Apr 18, 2025Amendment$30,661,253$11,537,013$19,124,24047Jan 25, 2024sec.gov
Jan 29, 2025Amendment$30,661,253$9,865,646$20,795,60741Jan 25, 2024sec.gov
Jan 22, 2025Amendment$30,661,253$9,565,646$21,095,60740Jan 25, 2024sec.gov
Dec 17, 2024Amendment$30,661,253$8,610,539$22,050,71437Jan 25, 2024sec.gov
Nov 6, 2024Amendment$30,661,253$6,566,766$24,094,48731Jan 25, 2024sec.gov
Oct 16, 2024Amendment$30,661,253$4,789,837$25,871,41624Jan 25, 2024sec.gov
Sep 26, 2024Amendment$30,661,253$4,198,753$26,462,50021Jan 25, 2024sec.gov
Aug 12, 2024Amendment$30,661,253$4,023,753$26,637,50019Jan 25, 2024sec.gov
Jul 10, 2024Amendment$30,661,253$2,913,131$27,748,12214Jan 25, 2024sec.gov
May 21, 2024Amendment$30,661,253$1,946,858$28,714,39510Jan 25, 2024sec.gov
Mar 26, 2024Amendment$30,661,253$1,551,858$29,109,3957Jan 25, 2024sec.gov
Mar 12, 2024Amendment$30,661,253$517,406$30,143,8474Jan 25, 2024sec.gov
Feb 21, 2024Amendment$30,661,253$417,406$30,243,8473Jan 25, 2024sec.gov
Jan 31, 2024New notice$30,661,253$148,529$30,512,7241Jan 25, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
N/A NexPoint Real Estate Advisors IV, L.P.Executive OfficerSponsor of the Issuer
Brian MittsExecutive OfficerAuthorized Signatory of the Issuer
Matt McGranerExecutive OfficerAuthorized Signatory of the Issuer
N/A NREA LS III Manager, LLCExecutive OfficerManager and Signatory Trustee of the Issuer
N/A NREA LS III Contributor, LLCExecutive OfficerContributor of the Issuer

Other real estate companies in Texas that filed recently

Every Form D from the week of Aug 10, 2026 · All recent filings in Texas · All recent Other Real Estate filings

Read from SEC EDGAR. Amount sold is what NexPoint Life Sciences III DST reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.